`ASSOCIATE
`
`(202) 772-8525
`EHEENAN@STERNEKESSLER.COM
`
`September 4, 2018
`
`Commissioner for Patents
`PO Box 1450
`
`Alexandria, VA 223 13-1450
`
`Stems Resale?“
`
`'STERNE KESSLER GDLDSSTEEN 8: FOX
`
`Confirmation N0. 7085
`Art Unit 1643
`
`Attn: Mail Stop Amendment
`
`U. S. Utility Patent Application
`Appl. No. 15/310,132, §371(c) Date: November 10, 2016
`For: IMMUNOTHERAPY WITH BINDING AGENTS
`
`Inventors: GURNEY et al.
`
`Our Ref: 2293 . 1220001/PAC/E-H/M-S
`
`Commissioner:
`
`Transmitted herewith for appropriate action are the following documents:
`
`1.
`
`2.
`
`4.
`
`5.
`
`Reply to Restriction Requirement and Election of Species,
`
`First Supplemental Information Disclosure Statement,
`
`Form PTO/SB/08b equivalent (1 sheet), and
`
`A copy of cited document NPL15.
`
`These documents arefiled electronically.
`
`The US. Patent and Trademark Office is hereby authorized to charge any fee deficiency
`and any additional fees required to continue prosecution or appeal of this application (including
`issue fee, fees for net addition of claims or forwarding to appeal) or credit any overpayment to
`our Deposit Account No. 19-0036.
`
`Respectfully submitted,
`
`STERNE, KESSLER, GOLDSTEIN & FOX P.L.L.C.
`
`/Erin J. Heenan/
`
`Erin J. Heenan
`
`Agent for Applicant
`Registration No. 70,012
`
`PAC/E-H/M-S/dab
`Enclosures
`
`978617171docx
`
`
`Wahsfimm §§{1?le§‘3
`\tm‘x‘mwm $msm:\$< Sex R ms \NVew‘stm
`«
`\
`‘\
`\\* ‘x‘
`<
`,.
`-. w
`.--- >‘
`'
`A
`i
`v. <.\,-.
`Wat‘énbflf‘ Hfi‘wwm mwwmmmm
`
`